Violet Therapeutics
Cambridge
About Violet Therapeutics
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $10.6M
- Funding stage: Seed
- Last round: Seed (May 2023)
- Website: violettx.com
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/violet-therapeutics-87445 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.